Comment
Author: Admin | 2025-04-28
Lawsuits Over Ozempic, Wegovy, Mounjaro and Other GLP1-RA Drugs May Hinge on Label Warnings April 19, 2024 Lawyers indicate that that questions about whether the GLP-1 RA medication label warnings adequately disclose the risk of gastroparesis and other severe injuries will play a large role in the growing litigation. FDA Has Linked More Than 100 Deaths to Ozempic, Wegovy and Similar Drugs: Report April 15, 2024 By: Irvin Jackson Death reports linked to Ozempic and similar drugs indicate users suffered from intestinal masses, stomach paralysis, pancreatic cancer and seizures. Trulicity Lawsuit Filed Over GLP-1 Gastroparesis Side Effects April 10, 2024 By: Irvin Jackson Eli Lilly failed to warn users that side effects of Trulicity may cause gastroparesis, despite numerous studies, case reports and medical literature indicating that users may experience severe stomach paralysis. Concerns Rising Over Risk that Ozempic May Cause Birth Control to Fail April 01, 2024 By: Irvin Jackson Health experts urge women not to use Ozempic or similar drugs to increase fertility, due to increased risks of birth defects and miscarriage. Eli Lilly Warns About Potential Health Risks From Mounjaro, Zepbound Counterfeit Versions March 08, 2024 By: Irvin Jackson Drug maker plans to pursue legal remedies against compounding pharmacies, medical spas and other entities that claim to sell generic versions of Mounjaro and Zepbound. Lawsuit Over Mounjaro Intestinal Obstructions, Gastroparesis Diagnosis Filed Against Eli Lilly February 26, 2024 By: Irvin Jackson New York woman indicates she had to undergo an emergency resection of her bowels and now needs to use a colostomy bag as a result of gastroparesis and intestinal obstructions from Mounjaro Psychiatric Side Effects Linked to Ozempic, Wegovy and Other Popular GLP-1 Drugs in New Study February 20, 2024 By: Irvin Jackson Researchers noted that side effects of Ozempic and similar drugs were particularly linked to an increased risk in eating disorders, such as self-induced vomiting and fear of eating. FDA Cites Eli Lilly Manufacturing Facility for Quality Control, Falsified Documents: Reuters January 23, 2024 By: Katherine McDaniel The New Jersey production facility has a history or quality control problems over the last several years,
Add Comment